1
However, long-term data are lacking among women with gestational hypertension without proteinuria.
2
Maternal adverse pregnancy outcomes were pre-eclampsia, gestational diabetes, and gestational hypertension.
3
We ascertained gestational hypertension, pre-eclampsia, gestational diabetes and preterm birth diagnoses from medical records.
4
Patients: A total of 65 women with gestational hypertension at 24-26 weeks.
5
When looking at gestational hypertension and pre-eclampsia as outcomes, (multiple) logistic regression was used in the analysis.
1
The results were adjusted for maternal age, gestational age and pregnancy-induced hypertension.
2
During her last pregnancy, Michelle was diagnosed with pre-eclampsia, or pregnancy-induced hypertension.
3
Group 1 patients had a significantly higher incidence of pregnancy-induced hypertension and preterm birth.
4
Of all the interaction terms, only the bromocriptine by pregnancy-induced hypertension interaction was significant.
5
Incidence of pregnancy-induced hypertension or preeclampsia, gestational week at delivery and birthweight were recorded.
1
Conclusions: Antihypertensive therapy in pregnancy with Labetalol may have the potential to impair fetal behavior in low degrees hypertensive diseases of pregnancy.